Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections.
about
Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature reviewColistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapyNecrotizing fasciitis caused by Acinetobacter baumannii : A case reportEfficacy and safety of polymyxins for the treatment of Acinectobacter baumannii infection: a systematic review and meta-analysisNewer antibacterial drugs for a new century.Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter InfectionsA prospective study of the demographics, management and outcome of patients with acute kidney injury in Cape Town, South Africa.Colistin in the 21st century.ICU-associated Acinetobacter baumannii colonisation/infection in a high HIV-prevalence resource-poor setting.Antibiotic Resistance of Acinetobacter baumannii in Iran: A Systemic Review of the Published Literature.Meta-analysis of colistin for the treatment of Acinetobacter baumannii infectionPost-neurosurgical meningitis caused by acinetobacter baumannii: case series and review of the literature.Treatment of Acinetobacter infections.Can Pharmacokinetic and Pharmacodynamic Principles Be Applied to the Treatment of Multidrug-Resistant Acinetobacter?Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an update.Tobramycin for the treatment of bacterial pneumonia in children.Therapeutic options for Acinetobacter baumannii infections: an update.Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management.Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review.Clinical efficacy and safety of colistin treatment in patients with pulmonary infection caused by Pseudomonas aeruginosa or Acinetobacter baumannii: a meta-analysis.Strategies for the safe use of colistin.Epidemiology of multidrug-resistant Acinetobacter baumannii strains in Iran: a systematic review and meta-analysis.Acinetobacter baumannii: A Brief Account of Mechanisms of Multidrug Resistance and Current and Future Therapeutic ManagementTrend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system.Variables determining the development of colistin-associated renal impairment.Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center.Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patients.A retrospective study on the effects of colistin therapy in children with multidrug-resistant Gram-negative bacterial pathogens: impact of HIV status on outcome.[Colistin : renaissance of an old antibiotic?].
P2860
Q26796605-44F910FA-DD54-4007-9EE9-232DECDEC624Q27014993-D57D3101-3D36-4E0C-B765-A794BEDCF550Q28293095-52EB2AF5-7D61-491E-A0CD-403CCC405468Q28539496-2AD1192D-1C82-4C8D-8ED4-F75AF4C05810Q30433333-797ADA14-A356-47CA-B67F-E984232EBE8DQ33732524-87041A07-DEBA-4271-A4C2-4D12EF29F9E7Q33751754-14F5EB58-DDC3-4BDD-A2D2-471215C4ACDBQ33847509-B0544DBB-D494-4B53-AE10-F470787C12E5Q34540725-BBA40B91-91C0-4B30-A8C6-4434659CE5EAQ35543456-1E58A63E-8036-4DA1-A18B-61715D1010ABQ36310173-0A78DF21-EF51-40A6-A2DA-DAAB1DF048BAQ36493352-2C575395-173E-4A5C-A46D-D7F41C333496Q37704397-F6197743-40A6-49F3-ACC5-2113B2CE8560Q37838126-F31E9A84-D2C4-4A2D-9101-885E6B98F6B0Q37869910-926A0E68-5FB7-4AD4-A82B-F73F30053B74Q37915360-86BC8878-B388-4819-A559-F8CDE680CC31Q37980230-9979081D-6C05-4BBB-A913-B414DD947B74Q38049332-8D95617C-AC93-405A-A7C4-3A51CA5062A1Q38097120-61167908-2E76-407A-B185-D29954F0CF55Q38212031-5D5F922D-EC9F-4D55-A3FA-D97110726F4AQ38414785-EAF1D29B-E879-4EA3-91A2-B90A20A1F5E1Q38548658-5FA319BF-513E-4023-BEC7-66AF7107B1D8Q38722054-69441CA8-F411-402E-AACE-5E32B9BBF35FQ39279278-4D628BE4-BBBD-4007-BDFC-AAE76ABAC2EEQ39391864-740CEBB5-90B8-4D0D-8F3A-D0012D7F661DQ39922949-DE032B41-DB4C-442B-B465-416F46A724B0Q41281850-554DB30D-7FB4-4728-BD79-B47BC24CEC8EQ41676553-C79AE76E-FC7A-4FD9-9026-4C0C2AC3A966Q42263849-CD1CEACB-DF85-4870-B093-024404FD3A55Q44464154-A326D5FD-9382-4F2B-8052-BDF5AFDB16C0Q46142029-8793C8D3-E352-4276-8AC3-8AD4B9A89750
P2860
Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Safety and effectiveness of co ...... tobacter baumannii infections.
@ast
Safety and effectiveness of co ...... tobacter baumannii infections.
@en
type
label
Safety and effectiveness of co ...... tobacter baumannii infections.
@ast
Safety and effectiveness of co ...... tobacter baumannii infections.
@en
prefLabel
Safety and effectiveness of co ...... tobacter baumannii infections.
@ast
Safety and effectiveness of co ...... tobacter baumannii infections.
@en
P2860
P50
P356
P1476
Safety and effectiveness of co ...... tobacter baumannii infections.
@en
P2093
Colleen Bamford
Ronald Gounden
P2860
P2888
P356
10.1186/1471-2334-9-26
P577
2009-03-09T00:00:00Z
P5875
P6179
1030493693